Regioselective 2-hydroxylation of 17β-estradiol by rat cytochrome P4501B1

Previous work demonstrated that human cytochrome P4501B1 (CYP1B1) forms predominantly 4-hydroxyestradiol (4-OHE2), a metabolite which is carcinogenic in animal models. Here, we present results from kinetic studies characterizing the formation of 4-OHE2 and 2-hydroxyestradiol (2-OHE2) by rat CYP1B1 using 17β-estradiol (E2) as a substrate. K m and K cat values were estimated using the Michaelis-Menten equation. For rat CYP1B1, the apparent K m values for the formation of 4-OHE2 and 2-OHE2 were 0.61 ± 0.23 and 1.84 ± 0.73 μM; the turnover numbers (K cat) were 0.23 ± 0.02 and 0.46 ± 0.05 pmol/min/pmol P450; and the catalytic efficiencies (K cat/K m) were 0.37 and 0.25, respectively. For human CYP1B1, the apparent K m values for the formation of 4-OHE2 and 2-OHE2 were 1.22 ± 0.25 and 1.10 ± 0.26; the turnover numbers were 1.23 ± 0.06 and 0.33 ± 0.02; and the catalytic efficiencies were 1.0 and 0.30, respectively. The turnover number ratio of 4- to 2-hydroxylation was 3.7 for human CYP1B1 and 0.5 for rat CYP1B1. These results indicate that, although rat CYP1B1 is a low K m E2 hydroxylase, its product ratio, unlike the human enzyme, favors 2-hydroxylation. The K i values of the inhibitor 2,4,3',5'-tetramethoxystilbene (TMS) for E2 4- and 2-hydroxylation by rat CYP1B1 were 0.69 and 0.78 μM, respectively. The K i values of 7,8-benzoflavone (α-NF) for E2 4- and 2-hydroxylation by rat CYP1B1 were 0.01 and 0.02 μM, respectively. The knowledge gained from this study will support the rational design of CYP1B1 inhibitors and clarify results of CYP1B1 related carcinogenesis studies performed in rats